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Background: Several studies have hypothesized that genes regulating the components of the serotonin system,
including serotonin transporter (5-HTTLPR) and serotonin 1 B receptor (5-HT1B), may be associated with alcoholism,
but their results are contradictory because of alcoholism’s heterogeneity. Therefore, we examined whether the 5-
HTTLPR gene and 5-HT1B gene G861C polymorphism are susceptibility factors for a specific subtype of alcoholism,
antisocial alcoholism in Han Chinese in Taiwan.
Methods: We recruited 273 Han Chinese male inmates with antisocial personality disorder (ASPD) [antisocial
alcoholism (AS-ALC) group (n= 120) and antisocial non-alcoholism (AS-N-ALC) group (n= 153)] and 191 healthy
male controls from the community. Genotyping was done using PCR-RFLP.
Results: There were no significant differences in the genotypic frequency of the 5-HT1B G861C polymorphism
between the 3 groups. Although AS-ALC group members more frequently carried the 5-HTTLPR S/S, S/LG, and LG/LG
genotypes than controls, the difference became non-significant after controlling for the covarying effects of age.
However, the 5-HTTLPR S/S, S/LG, and LG/LG genotypes may have interacted with the 5-HT1B G861C C/C
polymorphism and increased the risk of becoming antisocial alcoholism.
Conclusion: Our study suggests that neither the 5-HTTLPR gene nor the 5-HT1B G861C polymorphism alone is a risk
factor for antisocial alcoholism in Taiwan’s Han Chinese population, but that the interaction between both genes
may increase susceptibility to antisocial alcoholism.
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Alcoholism (also: alcohol dependence) is a complex, het-
erogeneous disorder that is influenced by multiple genes
as well as sociocultural factors [1,2]. Twin studies have
shown that genetic factors account for about 50-60% of
the overall variance in alcoholism [3-5]. Many candidate
genes have been studied; however, the results are contro-
versial. Therefore, to reduce the heterogeneity of alcohol-
ism by proper subtyping is important. In addition, a* Correspondence: rblu@mail.ncku.edu.tw
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reproduction in any medium, provided the origgene-to-gene interaction approach may be more reveal-
ing than a single-gene approach for studying alcoholism.
By using appropriate subtypes of alcoholism and the
gene-to gene interaction approach, the results may be
more conclusive.
Cloninger (1987) identified two subtypes of alcoholism.
Type I alcoholism is characterized by late onset, more
psychological dependence, and anxious/depressed per-
sonality traits. Individuals with type II alcoholism are
characterized by early onset, a higher familial risk for al-
coholism, and antisocial personality traits [1]. We previ-
ously subdivided alcoholism into three categories: pure,
anxious/depressive, and antisocial (AS) [6]. We showed
that antisocial alcoholism (AS-ALC; alcoholism comorbidtd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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some extent with Cloninger’s type II alcoholism, have a
strong genetic predisposition to alcoholism and different
genetic polymorphisms than do other subtypes of alcohol-
ism. The protective effect of the ADH1B*2 allele against
alcoholism vanished in antisocial alcoholics [6], and the
protective effect of the ALDH2*2 allele might disappear in
individuals with antisocial personality disorder (ASPD)
and carrying the MAOA-uVNTR 4-repeat allele [7]. Anti-
social alcoholics had higher novelty-seeking scores with an
interaction between the DRD2 TaqI A1 (A1A1 or A1/A2)
and 5-HTTLPR S/S genotype [8]. Moreover, antisocial alco-
holics had different polymorphisms of the serotonin (5-HT)
receptor 1B A-161T from other subtypes of alcoholics [9].
All the evidence supports the typology of alcoholism and
the particular genetic vulnerability of antisocial alcoholics.
Numerous studies have reported reduced brain sero-
tonin (5-hydroxytryptamine, 5-HT) function in patients
who are similar to antisocial alcoholics. Lower cerebro-
spinal fluid concentration of the 5-HT metabolite 5-
HIAA (5-hydroxyindoleacetic acid) has been found in
early-onset antisocial alcoholics [10], impulsive alcoholic
criminals [11,12], and alcoholic fire setters [13,14]. In
addition, the variation of the central 5-HT system has
been shown to modulate alcohol consumption and may
contribute to the risk of alcoholism [15-17]. Genes en-
coding the 5-HTT gene (the serotonin transporter pro-
tein; genetic locus SLC6A4) and 5-HT receptor, which
may cause different levels of activity of 5-HTT, have
been examined as candidate genes for the risk of alcohol-
ism. The polymorphism of the 5-HTT-linked promoter
region (5-HTTLPR), which contains an insertion-deletion
of two 22-bp repeats in a region of the promoter with
multiple 22- to 23-bp repeats [18], affects the expression
of serotonin transporter [19]. In vitro study, the short
variant (S-allele) of the 5-HTTLPR displayed reduced
transcriptional activity [19] as well as decreased sero-
tonin transporter expression and serotonin uptake in
lymphoblast cell lines [18]. 5-HTTLPR polymorphisms
were also correlated to the function of serotonin trans-
porter both in vivo imaging study [20] and in postmor-
tem brain study [21]. Human SPECT study showed that
homozygous carriers of the long allele (L/L) had an in-
crease in the availability of raphe serotonin transporter
[20]. Serotonin transporter mRNA levels in subjects with
S/L and S/S genotypes were also lower than in subjects
with the L/L genotype in postmortem brain study [21].
Although the S allele has been linked to a risk of alcohol-
ism [22,23] and to antisocial alcoholics or type II alco-
holics [24-26], this link is still controversial [20,27,28]. In
addition to the long and short alleles, other subtypes of
the L allele have been described [29]. The long variant
with an adenosine at single nucleotide polymorphism
(SNP) rs25531 (LA) has been reported to have higheractivity than the long variant with a guanine at rs25531
(LG) [30,31]. Furthermore, other uncommon alleles that
are longer than the L variant were found in several studies
[29,32-35]. The extra-long allele or “novel allelic variant”
were called XL variants with 15, 18,19, 20 or 22 repeats
with unknown function [29,32-35]. Hence, the past
dichotomous classification of 5HTTLPR into S and L
allele may not be sufficient and the association between
the tri-allelic 5-HTTLPR polymorphism (S, LA, LG) and
the risk of alcoholism or antisocial alcoholism remains
unknown.
The serotonin 1B receptors (5-HT1B) are located on
presynaptic and postsynaptic terminals and function as
both autoreceptors and heteroreceptors that mediate the
release of serotonin [36]. The 5-HT1B gene has been
associated with alcohol intake and aggression in animal
and human studies. An alcohol preference locus has
been mapped in mice to the region where 5-HT1B is
located [37]. 5-HT1B receptor knockout mice were
found to have increased aggressive behavior [38] and
increased spontaneous alcohol consumption [39]. In
human studies, of 16 reported polymorphisms of 5-
HT1B, the results of association studies that used the
G861C polymorphism remain inconsistent [40]. Some
studies associated polymorphisms of 5-HT1B G861C
with alcoholism [41] or antisocial alcoholism [42]. People
with the 5-HT1B 861C allele also had 20% fewer 5-HT1B
binding sites in the prefrontal cortex, which was the
same as the alcoholism group [43,44]. However, subse-
quent studies did not confirm the association [45-47].
The heterogeneity of alcoholism, as well as different
populations and ethnicities, may cause the discrepancy.
The prevalence rate of ASPD and antisocial behaviors
in individuals with alcohol use disorders ranges from
20% to 33% [48-50]. Because of their high comorbidity,
most studies have not distinguished the effects of ASPD
from those of alcoholism in Western populations [51].
Being able to specify whether the genes were involved in
pure ASPD (ASPD not comorbid with alcoholism (AS-
N-ALC)) or AS-ALC, or both, may clarify the nature of
these disorders and elucidate whether past genetic associa-
tions with AS-ALC were merely contributed by ASPD.
The aims of current study is to (1) investigate whether
the tri-allelic 5-HTTLPR polymorphism and 5-HT1B
G861C polymorphism are associated with AS-ALC in the
Han Chinese population in Taiwan, and (2) assess the
serotonergic genetic interaction between 5-HTTLPR and
5-HT1B G861C polymorphisms and antisocial alcoholism.
Methods
Participants and clinical assessments
This study was approved by the Institutional Review
Boards for the Protection of Human Subjects at the Tri-
Service General Hospital and National Cheng Kung
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(0.1%) of ASPD in Han Chinese in Taiwan [52], it is diffi-
cult to recruit study participants with ASPD from clinics
or from the community. Instead, we recruited 273 Han
Chinese men with ASPD from a prison in Taipei (north-
ern Taiwan) (n= 173) and a prison in Tainan (southern
Taiwan) (n= 100). The research protocol was reviewed
and approved by the Taiwan Ministry of Justice, which
permitted us to collect blood samples from the partici-
pants. The procedures were fully explained to each par-
ticipant before they gave written informed consent;
however, there were no advocates for the inmates
present when they were asked to sign the consent form.
Participants were told that they were free to drop out of
or to join the study at any time. We offered several com-
pensatory benefits: 1) a free physical examination, 2) liver
and renal function tests, and 3) and free treatment or as-
sistance in transferring those with psychiatric or physical
illnesses to hospitals. Each participant was initially evalu-
ated by an attending psychiatrist and then interviewed
by a psychologist well-trained in using the DSM-IV and
the Modified Chinese Version of the Modified Schedule
of Affective Disorder and Schizophrenia-Life Time
(SADS-L) [53,54]. The inter-rater reliability of the Chinese
version of the modified SADS-L was good with the kappa
values range from 0.71 to 1.00 in several major mental ill-
ness [54]. The SADS-L was also found to be adequate for
diagnosing ASPD with or without alcoholism [6,55-57].
Participants with major mental illnesses including schizo-
phrenia, bipolar disorder, multiple substance abuse, or
other organic mental disorders, and those who refused to
participate (< 10%) were excluded from the study. None
of the participants was taking any kind of medication. All
who met the criteria for a diagnosis of antisocial personal-
ity disorder with or without alcoholism were assigned to
the AS-ALC group) (n=120) or the AS-N-ALC group
(n=153), respectively.
The healthy control group included 191 male volun-
teers recruited from the community. The Chinese ver-
sion of the SADS-L was used to screen their psychiatric
conditions. All controls were free of present and past
major and minor mental illness (affective disorder,
schizophrenia, anxiety disorder, personality disorder, al-
cohol abuse and dependence, and illegal substance use
disorder), and none had a family history of psychiatric
disorders among their first-degree relatives.
Blood samples and genotyping for 5-HTTLPR and 5-HT1B
G861C polymorphisms
Twenty milliliters of blood was drawn from each partici-
pant, and standard methods were used to extract gen-
omic DNA from the leukocytes. The genotypes of 5-
HTTLPR functional polymorphisms were genotyped using
polymerase chain reaction plus restriction fragment lengthpolymorphism (PCR-RFLP) analysis [18]. The A/G SNP of
the L allele were determined using a modified protocol
[58]. The G861C polymorphism of the 5-HT1B gene was
genotyped using a modified protocol [42].
Statistical analyses
One-way analysis of variance (ANOVA) and the Bonfer-
roni Post Hoc Test were used to determine the mean age
differences between the subgroups. The difference in
genotype frequency of 5-HTTLPR and 5-HT1B G861C
polymorphisms between three groups was calculated
using the Pearson χ2 test (2-tailed). The 5-HTTLPR poly-
morphisms in AS-ALC and AS-N-ALC groups were
further stratified by the 5-HT1B G861C polymorphism
using the χ2 tests. Logistic regression analysis was used
to examine the main effect and gene-to-gene interaction
of the 5-HTTLPR and 5-HT1B G861C polymorphisms
for the risk of antisocial alcoholism. Both the SA and the
SG alleles were recorded as the S allele because there is
no functional difference in the SNPs [59]. Because past
studies found that S and LG carrier had lower function
and expression of serotonin transporter [18-20,60], we
divided the 5-HTTLPR polymorphisms into 2 groups,
low-functional (S/S, S/LG, LG/LG) and high-functional
(S/LA, LG/LA, LA/LA, S/XL, LA/XL, LG/XL), for data ana-
lysis. There was only 8 participants carried the LALA
genotype in our study, so we did not separate the homo-
zygous LA carries from heterozygous LA carriers into an-
other group. SPSS for Windows 17.0 (SPSS Inc., Chicago,
IL, USA) was used for all statistical analyses.
The power estimation was calculated using G-power
3.1 software [61,62]. Our total sample size (n= 464) had
a power of 0.58 to detect a small effect (effect size = 0.1),
of 0.99 to detect a medium effect (effect size = 0.3), and
of 1.00 to detect a large effect (effect size = 0.5) of geno-
type distributions.
Results
Healthy controls were significantly older than those in the
AS-ALC (P=0.004) and AS-N-ALC groups (P=0.009;
mean age: F=6.87; df=2, 461 (Table 1). A Bonferroni post
hoc test did not show a significant age difference between
the AS-ALC and AS-N-ALC groups.
Genotype distributions of 5-HTTLPR and 5-HT1B
G861C were in Hardy-Weinberg equilibrium (5-HTTLPR:
P=0.75 in AS-ALC and P=0.22 in AS-N-ALC; 5-HT1B
G861C: P=0.07 in AS-ALC and P=0.72 in AS-N-ALC).
The distribution of the 5-HTTLPR and 5-HT1B G861C
genotypes was not significantly different between the
three groups (Table 2). However, there was a higher fre-
quency of the low-functional 5-HTTLPR polymorphism
(S/S, S/LG, LG/LG) in the AS-ALC group than in the con-
trol group (Table 2). After stratifying the 5-HTTLPR poly-
morphisms with the 5-HT1B G861C polymorphism, a
Table 1 Demographic data
Group n Age (years) F P-value
AS-ALC 120 32.4 ± 7.6 6.87 0.001
AS-N-ALC 153 32.8 ± 7.5
Controls 191 35.5 ± 9.4
AS-ALC, antisocial alcoholism; AS-N-ALC, antisocial personality disorder without
alcoholism.
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morphisms was found after controlling for the 5-HT1B
G861C C/C genotype for both AS-ALC versus controls
and AS-ALC versus AS-N-ALC (Table 3). A logistic re-
gression analysis, done to control the possible covarying
effect of age, showed that the 5-HTTLPR and 5-HT1B
G861C genotypes were not significantly different between
the AS-ALC and control groups or the AS-ALC and the
AS-N-ALC groups (Table 4). However, the regression did
reveal a significant interaction between the 5-HTTLPR
and 5-HT1B G861C genes. Compared with AS-N-ALC and
control groups, the interaction between the 5-HTTLPR
low-functional group (S/S, S/LG, LG/LG genotype) and the
5-HT1B G861C C/C genotype may increase the risk of be-
coming an antisocial alcoholic (P=0.04, odds ratio (OR)=
6.22 and 5.76, respectively) (Table 4).Discussion
We found that interaction between the 5-HTTLPR S/S,
S/LG, LG/LG genotypes and the 5-HT1B G861C C/C gen-
otypes was associated with the AS-ALC group compared
with the control and AS-N-ALC groups. Unlike past
studies [24-26,43], we did not find an association be-
tween the 5-HTTLPR or the 5-HT1B G861C polymorph-
isms with AS-ALC. Although the AS-ALC group seemed
to have a higher frequency of the 5-HTTLPR S/S, S/LG,
LG/LG genotype than did the control group, when the
effect of age was controlled by logistic regression, the dif-
ference was not significant.
The interaction between the 5-HTTLPR S/S, S/LG,
LG/LG and the 5-HT1B G861C C/C genotypes may
result in reduced brain serotonin function. BecauseTable 2 Genotype distribution and frequency of the 5HTTLPR
5HTTLPR genotype frequency (%)
Group n S/S, S/LG, LG/LG S/LA, LG/LA, LA/LA,
S/XL, LA/XL, LG/XL
χ² P-valu
AS-ALC 120 90 (75.0) 30 (25.0) 5.39 0.02a
AS-N-ALC 153 100 (65.4) 53 (34.6) 2.95 0.09b
Controls 191 119 (62.3) 72 (37.7) 5.50 0.06c
AS-ALC: Antisocial alcoholism;
AS-N-ALC: Antisocial personality disorder without alcoholism.
a AS-ALC vs. Healthy Controls.
b AS-ALC vs. AS-N-ALC.
c AS-ALC vs. AS-N-ALC vs. Controls.
*P< 0.05.patients with the 5-HT1B 861 C allele were found with
fewer 5-HT1B binding sites in the prefrontal cortex
[43,44] and the 5-HTTLPR S/S, S/LG, LG/LG was the low-
functional group [30,31], our results imply that only the
combined effect of serotonergic dysfunction from the
studied genes, but not from individual genes, may be
associated with risk for antisocial alcoholism. Several
other reasons may also account for our positive finding.
First, past studies compared the 5-HTTLPR polymorph-
ism between antisocial alcoholics and healthy (without
ASPD and non-alcoholics) controls. Because ASPD has
been linked to the 5-HTTLPR polymorphism [63-65], we
tried to control for the confounding effect of ASPD by
comparing antisocial alcoholics with healthy controls and
antisocial non-alcoholics. Second, our healthy control
group belonged to a super-control group that excluded
any other major or minor mental illness, while in other
studies [25,26], the authors included only individuals from
unscreened community controls and no antisocial non-
alcoholics. Moreover, we used a tri-allelic functional 5-
HTTLPR polymorphism instead of a bi-allelic polymorph-
ism. All these factors may have caused results different
from those of other reports.
We found no association between antisocial alcoholism
and the 5-HT1B G861C polymorphism. A previous study
[43] showed that the frequencies of the 5HT1B 861 C allele
varied widely among different ethnic groups, ranging from
20% in African-Americans to 36% in Hispanics and 42% in
Asians. In our current study, the frequency of the 5-HT1B
C allele (48.9% in the control group, 49.6% in the AS-ALC
group, and 47.1% in the AS-N-ALC group) was higher than
in previous reports. We also added an AS-N-ALC group to
decrease the effect of ASPD. Different populations and eth-
nicities may also partially explain our different results.
Our past study [66] showed that antisocial alcoholics
and antisocial non-alcoholics shared a similar genetic
vulnerability of dopamine-related genes, which was dif-
ferent from healthy controls. However, in the present
study, we did not find the same distributions of the 5-
HTTLPR and 5-HT1B genes in the three groups. It
seems that the antisocial non-alcoholics and healthyand 5HT1B G861C polymorphism
5HT1B G861C genotype frequency (%)
e G/G G/C C/C χ² P-value
* 25 (20.8) 70 (58.3) 25 (20.8) 4.58 0.10a
44 (28.8) 74 (48.4) 35 (22.9) 3.07 0.22b
55 (28.8) 88 (46.1) 48 (25.1) 5.04 0.28c
Table 3 5HTTLPR genotype frequency after stratification








G/G AS-ALC 15 (60.0) 10 (40.0) 0.023 0.878
Controls 32 (58.2) 23 (41.8)
G/C AS-ALC 53 (75.7) 17 (24.3) 1.086 0.297
Controls 60 (68.2) 28 (31.8)
C/C AS-ALC 22 (88.0) 3 (12.0) 7.509 0.006*
Controls 27 (56.3) 21 (43.8)
AS-ALC vs. AS-N-ALC
G/G AS-ALC 15 (60.0) 10 (40.0) 0.784 0.376
AS-N-ALC 31 (70.5) 13 (29.5)
G/C AS-ALC 53 (75.7) 17 (24.3) 3.075 0.079
AS-N-ALC 46 (62.2) 28 (37.8)
C/C AS-ALC 22 (88.0) 3 (12.0) 3.863 0.049*
AS-N-ALC 23 (65.7) 12 (34.3)
*P< 0.05
AS-ALC, antisocial alcoholism; AS-N-ALC, antisocial personality disorder without
alcoholism.
Table 4 Logistic regression analysis of 5HTTLPR gene and
5HT1B receptor gene G861C polymorphism and their
interaction for the risk of antisocial alcoholism (AS-ALC)
AS-ALC
Models B OR 95% CI P-value
Model 1
5HTTLPR low functional group −0.47 0.62 0.22-1.75 0.37
5HT1B G861C G/C −0.21 0.81 0.29-2.27 0.69
5HT1B G861C C/C −1.13 0.32 0.07-1.46 0.14
5HTTLPR low-functional
group*5HT1B G861C G/C
1.09 2.97 0.84-10.44 0.09
5HTTLPR low-functional
group*5HT1B G861C C/C
1.83 6.22 1.10-35.27 0.04*
Model 2
5HTTLPR low-functional group 0.14 1.15 0.43-3.07 0.78
5HT1B G861C G/C 0.49 1.63 0.61-4.35 0.33
5HT1B G861C C/C −1.26 0.28 0.07-1.19 0.09
5HTTLPR low-functional
group*5HT1B G861C G/C
0.07 1.07 0.32-3.65 0.91
5HTTLPR low-functional
group*5HT1B G861C C/C
1.75 5.76 1.09-30.44 0.04*
5HTTLPR low-functional group: S/S, S/LG, LG/LG
5HTTLPR high-functional group: S/LA, LG/LA, LA/LA, S/XL, LA/XL, LG/XL
B, coefficients; CI, confidence interval; OR, odds ratio
Model 1, reference groups are: 5HTTLPR high-functional group, 5HT1B G861C
G/G genotypes, and AS-N-ALC group; covarying for age
Model 2, reference groups are: 5HTTLPR high-functional group, 5HT1B G861C
G/G genotypes, and controls; covarying for age
*P< 0.05.
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serotonin-related genes, one different from that of the
antisocial alcoholics. We may speculate that other sero-
tonin-related genes have the same distribution between
individuals with ASPD and the general population. In
addition, serotonin may modulate the reinforcement pro-
cesses, possibly through complex interactions with the
mesolimbic dopamine system [60,67] and the regulatory
functions of several serotonin receptor subtypes, includ-
ing 5-HT1B receptor [68-70]. The interaction of the
dopaminergic and serotonergic neurotransmitter systems
in the nucleus accumbens and the ventral striatum is
thought to be critical in addiction [60,70,71]. Further-
more, enzymes involved in dopamine metabolism will
also metabolize serotonin. Serotonin is initially metabo-
lized to 5-hydroxyindole-3-acetaldehyde (5-HIAL) by
monoamine oxidase (MAO) [72], and then oxidized to
5-hydroxyindole-3-acetic acid (5-HIAA) by aldehyde
dehydrogenase (ALDH) [73]. We have reported [74] that
the dopamine D2 receptor gene interacted with the 5-
HTTLPR gene in antisocial alcoholics with specific per-
sonality traits. Hence, additional studies to explore the
associations among the 5-HTTLPR, the 5-HT1B gene, 5-
HT metabolic enzyme-related genes, and dopamine-
related genes will be required to study the pathogenesis
of AS-ALC.
Our study has several limitations. First, the study
populations in the AS-ALC and AS-N-ALC groups were
small. In addition, the cell size with the significant find-
ing was also small, which may cause the risk of false
positive results. Larger study populations are needed.
Second, there were few participants with the 5-HTTLPR
LA/LA genotype, and about 3.8% with the 5-HTTLPR XL
allele, which is different from other ethnic groups [30]. It
may be feasible to divide those with the 5-HTTLPR S/LA,
LG/LA, LA/LA, S/XL, LA/XL, LG/XL genotypes into a
high-functional group and those with the S/S, S/LG, LG/
LG genotypes into a low-functional group for statistical
analysis according to past study results [18-20,60]. Al-
though the function of the 5-HTTLPR XL allele remains
unknown, one study had speculated that it may function
as an L allele [75]. However, additional study will be
required to test its function since a significant proportion
of Han Chinese carry this allele [75]. Finally, it is very
likely that individuals with ASPD may belong to a spe-
cific group since members of both the AS-ALC and AS-
N-ALC groups were all recruited from jail, which caused
sampling biases. In addition, we used controls without
any past psychiatric history from the community. Re-
gardless of alcoholism, the inmate participants with
ASPD were substantially different from the healthy com-
munity participants [75]. It is necessary to be aware of
the possibility of false-positive results when comparing
these phenotypes with super-normal controls42.
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holism is associated with the interaction between the 5-
HTTLPR and 5-HT1B G861 polymorphisms. Additional
studies to examine the 5-HTTLPR and 5HT1B G861C
gene polymorphisms and their interaction effects with
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